Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT.

Brown, Sarah; Everett, Colin C; Naraghi, Kamran; Davies, Claire; Dawkins, Bryony; Hulme, Claire; McCabe, Christopher; Pavitt, Sue; Emery, Paul; Sharples, Linda; Buch, Maya H

Brown, Sarah; Everett, Colin C; Naraghi, Kamran; Davies, Claire; Dawkins, Bryony; Hulme, Claire; McCabe, Christopher; Pavitt, Sue; Emery, Paul; Sharples, Linda; Buch, Maya H.

Affiliation

Brown S; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Everett CC; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Naraghi K; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Davies C; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
Dawkins B; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Hulme C; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
McCabe C; Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada.
Pavitt S; Dental Translational and Clinical Research Unit, University of Leeds, Leeds, UK.
Emery P; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Sharples L; National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Buch MH; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Health Technol Assess ; 22(34): 1-280, 2018 06.

Article de En | MEDLINE | ID: mdl-29900829

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Polyarthrite rhumatoïde / Facteur de nécrose tumorale alpha / Antirhumatismaux Type d'étude: Clinical_trials / Guideline / Health_technology_assessment / Prognostic_studies Aspects: Patient_preference Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Health Technol Assess Sujet du journal: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Année: 2018 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google